Navigation Links
Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
Date:4/30/2009

alidation for us of what we have accomplished in the last few years.

"We are going to bring scientific expertise and our global network into the partnership and gradually continue our financial commitment. Our joint venture with Victhom's Neurobionix division will strengthen our research and development activities in neurostimulation over the long term. As a growing global medical technology company, Otto Bock HealthCare has the strength to ensure that the developments and products in our product range will reach successfully the global healthcare markets and increase the quality of life of the patients in their daily life", says Hans Georg Näder, President and CEO of Otto Bock HealthCare, explaining the activity.

Further information about the proposed transaction and the terms and conditions of the concurrent plan of arrangement will be available on SEDAR (www.sedar.com).

Update on Filing of Annual Disclosure Documents

In accordance with NP 12-203 and as previously announced, Victhom had voluntarily requested that the Autorite des marches financiers and other Canadian securities regulatory authorities issue a temporary order that prohibits certain directors, officers and insiders of Victhom from trading in securities of Victhom for as long as the annual financial statements, CEO and CFO certifications, and related MD&A and AIF are not filed (the "Management Cease Trade Order").

Following the above announcement, which constitutes a material change respecting Victhom and its activities, Victhom anticipates that the release of its annual financial statements, CEO and CFO certifications and related MD&A and AIF will occur in the next few days and that Victhom will apply to relevant authorities afterwards to request the revocation of the Management Cease Trade Order.

About Victhom

Victhom discovers, develops and manufacture
'/>"/>

SOURCE VICTHOM HUMAN BIONICS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)
2. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
3. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
4. Victhom announces the completion of the second phase of the apnea therapy development
5. Victhom Announces Launch of Enhanced Company Website
6. Victhom to Participate in the OneMedPlace Finance Forum
7. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
10. E&K Scientific Announces Partnership with Sciformatix
11. PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... ,Who: David Appia, French Ambassador for Internat...st in France Agency, , , , ,What: Ambassador Appi...t pro-business initiatives adopted by France to fu...andscape for innovation and development., , ,When:...
(Date:11/24/2009)...NTA CRUZ, Calif., Nov. 24 Two more...enter, the nation,s leading online job board and c...Northwestern and Columbia University are now membe...cience training Institutions. ,, The job board,...ates in the life sciences. While there are hundred...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PRNews...DCGN ) today announced that it has received notice...company,s common stock will be,suspended as of Nov...h the,Securities and Exchange Commission, which wi...sdaq, unless the company files an appeal to the Na...
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...Germany, August 1 , - Further Focus on Pharma & L...s business in technical plastic,systems. The busin...omponents for suppliers to the automobile industry...e science. For this purpose the sale process,has b...r bids., "Through the sale of the technical plast...
...if., July 31 Thermage, Inc.,(Nasdaq: THRM ), ann...sults,for the second quarter ended June 30, 2008, ... The Company will also host a conference call and,...Eastern Time (5:30 a.m.,Pacific) to discuss the fi.... The dial-in number for the conference call is 80...
...enue Grows 15 Percent Quarter-over-Quarter -, PAL...daq: CVTX ) today reported financial results for ...quarter ended June 30, 2008, the Company reported ...is compares to a net loss of $31.9,million, or $0...., 2008 and,$57.6 million, or $0.97 per share, for ...
Other Biology Technology:Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics 2CV Therapeutics Reports 2008 Second Quarter Financial Results 2CV Therapeutics Reports 2008 Second Quarter Financial Results 3CV Therapeutics Reports 2008 Second Quarter Financial Results 4CV Therapeutics Reports 2008 Second Quarter Financial Results 5CV Therapeutics Reports 2008 Second Quarter Financial Results 6CV Therapeutics Reports 2008 Second Quarter Financial Results 7
(Date:11/25/2009)...y assistant professors recently received funding f...nue research beneficial to understanding the envir...topher Blackwood, assistant professor in the Depar...o support two separate research projects. , His ...r Communities and Functions from the Leaf to the L...
(Date:11/24/2009)...g new doors to understanding how sounds associated...ine mammal or if they hear it at all. , The sam...at NASA uses to detect flaws in the space shuttle,...ntists to peek inside the giant head of a whale. T...replicas of a whale,s hearing anatomy using a brea...
(Date:11/24/2009)...n College of Medical Toxicology (ACMT) have signed... the Journal of Medical Toxicology (JMT), the of...0. It was previously published by the University ...l Toxicology , an international, peer-reviewed jou...actice of medical toxicology. The quarterly journ...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Toddlers Obese Kids Suffer Most From Smoke 61695 1Toddlers Obese Kids Suffer Most From Smoke 61695 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 1Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 14918 9Motts and The Sneaky Chef Give Holiday Favorites a Healthy Makeover 61690 1Motts and The Sneaky Chef Give Holiday Favorites a Healthy Makeover 61690 2Motts and The Sneaky Chef Give Holiday Favorites a Healthy Makeover 61690 3
...s E. coli bacterium, which has one-seventh the num...em involved in metabolism and metabolic regulation... would theoretically be capable of generating a hu...s at UCSD will report in the Dec. 27 issue of Proc... that Escherichia coli doesn,t gamble with its met...
...ult for a terrorist to obtain genes from the small...it,s not. Armed with a fake email address, a would... blocks of a deadly biological weapon online, and ...bering reality uncovered by a New Scientist invest...ing business of gene synthesis. Dozens of biotech ...
...consumers in Asia have received a little good news...rading nations remain deadlocked on how to move ah...he poor farmers of the developing world, research ...trategy to reduce poverty in the planet,s two most...rch shows that, in 1999, for every US$1 million in...
Other Biology News:How E. coli bacterium generates simplicity from complexity 2How E. coli bacterium generates simplicity from complexity 3The bioweapon is in the post 2The bioweapon is in the post 3The bioweapon is in the post 4Some good news for the world's poor 2Some good news for the world's poor 3Some good news for the world's poor 4
...re mismatch repair minus strains of E. coli. Use o...esized unmethylated strand (1), leading to high mu...h systems as the GeneEditor and Altered Sites II M... are recA+, therefore inserts containing highly re...
propidium iodide *1.0 mg/mL solution in water* from Molecular Probes (Invitrogen)
Sheep Anti-ECHIS OCCELATUS (VENOM) Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
Biology Products: